Report
Dave Nicoski ...
  • Ross LaDuke
EUR 46.20 For Business Accounts Only

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Underlyings
10x Genomics Inc Class A

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary oral drug candidate, MDX, to treat ADHD and other cognitive dysfunctions including Fragile X Syndrome. The most common available treatments for ADHD are stimulants that increase the brain chemicals dopamine and norepinephrine. Stimulants have significant side effects, and are classified as controlled substances which have significant potential for misuse, abuse and addiction. MDX is not a stimulant, and works with a different mechanism of action. MDX is a proprietary, combined rapid onset release formulation of the chemical Pyridoxine Pyroglutamate.

Aspen Group

Aspen Group is an educational technology holding company. It operates two universities, Aspen University and United States University. The company's primary focus is on the nursing profession, with most of the students across both universities are degree-seeking nursing students.

Beam Therapeutics

Beam Therapeutics operates as a biotechnology company. Through its subsidiaries, the company is a research stage biotechnology company committed to creating a new class of precision genetic medicines, based on the company's proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases.

Benefitfocus Inc.

Benefitfocus provides a cloud-based benefits management platform for buyers (consumers, employees and employers) and sellers (insurance brokers, carriers and suppliers). The Benefitfocus Platform enable organizations and individuals transact benefits. The company's employer, carrier, broker and supplier customers uses its platform to manage, scale and exchange benefits data. The Benefitfocus Platform is designed for consumers to access all of their benefits in one place. The company's solutions support medical benefit plans and non-medical benefits, such as, dental, life, disability insurance, income protection, digital health and financial wellness.

BioLife Solutions Inc

BioLife Solutions develops, manufactures and markets biopreservation tools for cells and tissues. The company's product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company's clinical grade HypoThermosol? FRS and CryoStor? biopreservation media products are marketed to the regenerative medicine, biobanking, and drug discovery markets. The company's customers include cell and gene therapy companies, research institutions, hospital-based stem cell transplant centers, and pharmaceutical companies.

Celcuity

Celcuity is a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. This enables physicians to select therapeutic that matches and inhibits a patient's cellular dysfunction.

Celsius Holdings Inc.

Celsius Holdings is engaged in the development, marketing, sale and distribution of functional calorie-burning fitness beverages under the Celsius? brand name. Celsius? burns calories by increasing a consumer's resting metabolism and provides energy. Celsius? uses ingredients and supplements such as green tea, ginger, calcium, chromium, B vitamins and vitamin C. The company also sells a powdered form of the active ingredients in its beverages in individual On-The-Go packets as well as several serving canisters. In addition, the company has a second line in its product portfolio, trainer's grade Celsius Heat?. Celsius Heat? is also a dietary supplement.

Chewy Inc. Class A

Chewy is a pure play e-commerce business geared toward pet products for dogs, cats, fish, birds, small pets, horses, and reptiles. The company serves its customers through its retail website, www.chewy.com, and its mobile applications and focuses on delivering exceptional customer service, a large selection of high-quality pet food, treats and supplies, price, convenience (including Chewy's Autoship subscription program), fast shipping, and hassle-free returns.

ClearPoint Neuro Inc

Cloudflare Inc Class A

CRISPR Therapeutics AG

Cross Country Healthcare Inc.

Cross Country Healthcare provides healthcare staffing, recruiting and workforce solutions. The company's business consists of three business segments: Nurse and Allied Staffing, which provides staffing, recruiting, and workforce solutions including temporary and permanent placement of travel and local branch-based nurse and allied personnel; Physician Staffing, which provides physicians, certified registered nurse anesthetists, nurse practitioners and physician assistants under its Medical Doctor Associates brand; and Other Human Capital Management Services, which is comprised of retained and contingent search services for physicians, healthcare executives, and other healthcare personnel.

Digi International Inc.

Digi International is a provider of Internet of Things (IoT) connectivity products and services. The company has two reportable operating segments: IoT Products and Services; and IoT Solutions. The company's IoT Products and Services segment provides products and services that assist original equipment manufacturers, enterprise and government customers create and deploy, IoT connectivity solutions. The company's IoT Solutions segment through its Digi Smart Solutions?, use sensors, gateways and cloud based applications to enable customers in food service, retail, healthcare, and transportation/logistics and education to monitor wirelessly the temperature of food and other perishable goods.

Etsy Inc.

Etsy provides sellers a marketplace with buyers along with a range of seller tools and services that are specifically designed to help its creative entrepreneurs generate more sales and scale their businesses. The company's platform includes the Etsy and Reverb Holdings, Inc. (Reverb) online marketplaces, its seller tools and services, its engaged sellers and buyers, and its technology. The company's primary marketplace, Etsy.com, is where buyers come to discover a selection of goods that are hard to find elsewhere. Reverb, the company's subsidiary, operates as a standalone marketplace. This two-sided marketplace connects buyers and sellers of new, used, and vintage musical gear from all over the world.

Frequency Therapeutics

Frequency Therapeutics operates as a biotechnology company. The company discovers and develops medicines and small molecule drugs for the treatment of patients with skin disorders, muscle regeneration, and gastrointestinal diseases. The company serves health care sector in the United States.

FuelCell Energy Inc.

FuelCell Energy is engaged in delivering distributed baseload power solutions. The company develops distributed power generation solutions and operates and provides service for the life of the power plant. The company's primary fuel cell products provide power generation for customers, including the sub-megawatt SureSource 250? and SureSource 400? in Europe, and the 1.4 megawatt (MW) SureSource 1500?, the 2.8 MW SureSource 3000?, and the 3.7 MW SureSource 4000? globally. The company's power plants utilize a variety of available fuels to produce electricity electrochemically, and produces none of the particulate pollutants associated with combustion-based power generation solutions.

FULGENT GENETICS

Fulgent Genetics is a holding company. Through its subsidiaries, the company is a technology company providing genetic testing and providing physicians with diagnostic information they can use to improve the quality of patient care. The company has developed a proprietary technology platform that allows it to provide test menu. The company performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels to meet customer needs. The company's test menu includes single-gene tests and panels that test for genetic conditions, including various cancers, cardiovascular diseases, neurological disorders and pediatric conditions.

Generation Bio

GrowGeneration

Guardant Health

Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. The company is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. The company's Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, the company is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.

HireQuest Inc.

Hovnanian Enterprises Inc. Class A

Hovnanian Enterprises, through its subsidiaries, designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments and is a builder of residential homes. The company has two operations: homebuilding and financial services. The company's financial services operations provide mortgage loans and title services to the customers of its homebuilding operations. The company markets and builds homes for first-time buyers, first-time and second-time move-up buyers, luxury buyers, active lifestyle buyers and empty nesters.

Ichor Holdings Ltd.

IDT Corp. Cl B

IDT operates primarily in the telecommunications and payment industries. The company has two reportable business segments: Telecom and Payment Services and net2phone. The company's Telecom and Payment Services segment provides retail telecommunications and payment offerings as well as wholesale international long-distance traffic termination. The company's net2phone segment provides unified cloud communications and telephony services to business customers.

Intellia Therapeutics Inc.

Intellia Therapeutics is a genome editing company focused on developing therapeutics utilizing a biological tool known as Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated 9 (Cas9). This is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid. The company utilizes its CRISPR/Cas9 platform across two areas: in vivo applications, in which CRISPR/Cas9 is therapy, delivered to target cells within the body; and ex vivo applications, in which CRISPR/Cas9 creates therapy of engineered human cells.

INVITAE CORP

Invitae is engaged in genetic testing services that support patient care throughout life's journey from inherited disease diagnosis, to family planning, to health screening with a network of patients, healthcare providers, biopharma and advocacy partners. The company's tests include genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions. In addition, the company's services also include screening and testing in reproductive health, including preimplantation and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis and pediatric developmental disorders.

KalVista Pharmaceuticals

KalVista Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. The company's product candidates are inhibitors of plasma kallikrein being developed for two indications: hereditary angioedema (HAE) and diabetic macular edema (DME). The company has a portfolio of oral plasma kallikrein inhibitors and developed various drug candidates into clinical trials in order to create oral therapies for both HAE and DME. The company has initiated a clinical study of KVD900 as a therapy for acute HAE attacks. The company has also commenced a clinical trial of KVD001, its DME drug candidate.

Korn Ferry

Korn Ferry is an organizational consulting firm. The company is engaged in the business of giving client awareness to its range of talent management solutions. The company's segments include: Executive Search, in which the company's services are used to fill executive-level positions, such as board directors, chief executive officers, chief operating officers, chief information officers, chief human resource officers and other senior executive officers; Advisory, which helps clients design their organization and shows them the way to compensate, develop and motivate their people; and RPO and Professional Search, which combines people, process personnel and intellectual property enabled technology.

Luna Innovations

Luna Innovations is engaged in optical technology, providing performance fiber optic test, measurement and control products for the telecommunications and photonics industries and distributed fiber optic sensing products for industries utilizing composite and other materials. The company's segments are: Products and Licensing, which develops, manufactures and markets distributed fiber optic sensing products, as well as communications test products; and Technology Development, which performs applied research towards developing new sensors including sensors for the purpose of corrosion, temperature, strain, pressure, structural health, and chemical detection.

Magic Software Enterprises Ltd.

Magic Software Enterprises is a provider of: proprietary application development and business process integration platforms; selected packaged vertical software solutions; as well as a vendor of software services and Internet Technology outsourcing software services. Co.'s software technology is used by customers to develop, deploy and integrate on-premise, mobile and cloud-based business applications. Co. provides a portfolio of services in the areas of infrastructure design and delivery, application development, technology consulting planning and implementation services, support services, cloud computing for deployment of applications and API's and supplemental outsourcing services.

Medifast Inc.

Medifast is engaged in the development of nutritional weight-management products and programs. The company's product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products, and vitamins. The company sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the Medifast?, OPTAVIA?, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home?, and Essential 1 brands. The Thrive by Medifast and Optimal Health by OPTAVIA lines include a variety of formulated bars, shakes, and smoothies for those who are maintaining their weight for long-term healthy living.

Moderna Inc.

Moderna is creating a new generation of medicines based on messenger RNA to improve the lives of patients. The company uses its platform to identify and develop new mRNA medicines. When the company identifies a combination of platform technologies or programs across mRNA technologies, delivery technologies, and manufacturing processes that can enable shared product features across multiple potential mRNA medicines, it groups those programs as a modality. The company has created six modalities including prohylactic vaccines; cancer vaccines; intratumoral immuno-oncology; localized regenerative therapeuctics; systemic secreted therapeutics; and systemic intracellular therapeutics.

Monolithic Power Systems Inc.

Monolithic Power Systems is a fabless semiconductor company. The company designs, develops and markets power solutions for systems found in consumer, computing and storage, automotive, industrial, communications and consumer applications. The company's primary product families include the following: Direct Current (DC) to DC products, which are used to convert and control voltages within a range of electronic systems such as portable electronic devices, wireless Local Area Network access points, computers, and monitors, automobiles and medical equipment; and Lighting Control Products, which include lighting control integrated circuits that are used in backlighting and general illumination products.

Myovant Science

NGM Biopharmaceuticals

NGM Biopharmaceuticals is a biopharmaceutical company. The company is focused on the following programs: Aldafermin, which is for the treatment of non-alcoholic steatohepatitis (NASH); NGM313 (MK-3655), which is for the treatment of NASH and type 2 diabetes; NGM120, which is designed to block the effects of elevated growth differentiation factor 15 levels on cancer anorexia/cachexia syndrome, and, possibly, tumors; NGM217, which is designed to restore pancreatic islet function and increase insulin production in patients with diabetes; NGM621, which is designed to decrease levels of this protein implicated in the dry form of AMD; and NGM395, which is for the treatment of metabolic syndrome.

Novavax Inc.

Novavax is a late-stage biotechnology company focused on the discovery, development and commercialization of vaccines to prevent serious infectious diseases. The company's vaccine candidates, including its primary candidates, ResVax? and NanoFlu?, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. The company's product pipeline targets a variety of infectious diseases. The company is also developing immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company's primary adjuvant, Matrix-M?, has been shown to improve immune responses and was well-tolerated in multiple clinical trials.

Ocular Therapeutix

Ocular Therapeutix is a biopharmaceutical company focused on the formulation, development and commercialization of therapies for diseases and conditions of the eye using its proprietary, bioresorbable hydrogel platform technology. The company has product candidates in clinical and preclinical development to treat post-surgical ocular pain and inflammation, allergic conjunctivitis, dry eye disease, among other conditions. The company's drug application, DEXTENZA? (dexamethasone ophthalmic insert) 0.4mg is for intracanalicular use for the treatment of ocular pain following ophthalmic surgery. The company is also assessing the potential use of its hydrogel platform technology in other areas of the body.

OncoSec Medical

Pliant Therapeutics

QAD Class A

QAD is a provider of cloud-based enterprise software solutions for manufacturing companies across the automotive, life sciences, consumer products, food and beverage, technology and industrial products industries. The company's solutions, called QAD Enterprise Applications, enable measurement and control of primary business processes that support operational requirements, including financials, manufacturing, demand and supply chain planning, customer management, business intelligence and business process management. The company also provides services including consulting, deployment, training, technical, development and integration to facilitate adoption of its cloud Enterprise Applications solution.

Rhythm Pharmaceuticals

Rhythm Pharmaceuticals is a biopharmaceutical company. The company's primary product candidate is setmelanotide, which is a melanocortin-4 (MC4) receptor agonist peptide for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. MC4 pathway deficiencies result in the disruption of satiety signals and energy homeostasis in the body, which, in turn, leads to intense feelings of hunger and to obesity. The company is evaluating setmelanotide for the treatment of six single gene related MC4 pathway deficiencies: pro-opiomelanocortin (POMC), leptin receptor, Bardet-Biedl syndrome, Alstrom syndrome, POMC heterozygous, and POMC epigenetic disorders.

Rubius Therapeutics

Rubius Therapeutics is a therapeutics company focused on using its platform to develop red cell therapeutics for the treatment of patients with severe diseases. The company is developing a class of cellular medicines, called Red Cell Therapeutics? for patients with cancer and autoimmune diseases based on two therapeutic modalities - potent cell-cell interaction and tolerance induction. The company's product candidates pipeline comprised of: RTX-240 for the treatment of solid tumors; RTX-240 for the treatment of acute myeliod leukemia; RTX-321 artificial antigen presenting cell program for the treatment of solid tumors; RTX-224 for the treatment of solid tumors; and RTX-T1D for the treatment of diabetes.

SolarWindow Technologies Inc

Spero Therapeutics

Spero Therapeutics is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant (MDR), bacterial infections. The company's product candidate, SPR994 (tebipenem pivoxil hydrobromide), is designed to be oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. The company also has a platform technology known as its Potentiator Platform, which includes two intravenous-administered agents, SPR206 and SPR741, that are active either alone or in combination with other standard of care agents and are designed to treat MDR Gram-negative bacteria in the hospital.

Stitch Fix Class A

Stitch Fix provides apparel, shoes, and accessories across categories, brands, product types, and price points. The company serves its clients in the following categories: Women's, Petite, Maternity, Men's, Plus, and Kids. The company carries a mix of third-party branded merchandise, including brands, and its own Exclusive Brands. The company also provides a variety of product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags. The company combines data science and human judgment to deliver one-to-one personalization to its clients at scale. The company helps its clients discover and buy what they love through data-driven, personalized, hand-selected shipments of apparel, shoes, and accessories.

Stoke Therapeutics

Stoke Therapeutics is a biotechnology company focused on treating the underlying causes of severe genetic diseases by upregulating protein expression. The company is developing antisense oligonucleotide, medicines that target ribonucleic acid (RNA), and modulate precursor-messenger RNA, splicing to upregulate protein expression where needed and with appropriate specificity to near normal levels. The company designed its primary product candidate, STK-001, to treat Dravet syndrome, a severe and progressive genetic epile.

Stratasys Ltd.

Strattec Security Corp.

Strattec Security designs, develops, manufactures and markets automotive access control products including mechanical locks and keys, electronically improved locks and keys, steering column and instrument panel ignition lock housings, latches, power sliding side door systems, power lift gate systems, power deck lid systems, door handles and related products for North American automotive customers. The company also supplies global automotive manufacturers through a joint venture relationship with WITTE Automotive (WITTE) and ADAC Plastics Inc. (ADAC). Under this relationship the company, WITTE and ADAC market the products of each company to global customers under the VAST Automotive Group brand name.

Sunnova Energy International

Sunnova Energy International is a residential solar and energy storage service provider. The company offers solar battery storage units, as well as maintenance, monitoring, and management services. The company serves customers in the United States and Northern Mariana Islands.

Tesla Inc

Tesla designs, develops, manufactures, sells and leases electric vehicles and energy generation and storage systems, and provides services related to its products. The company operates as two reportable segments: automotive, which includes the design, development, manufacturing, sales, and leasing of electric vehicles as well as sales of automotive regulatory credits; and energy generation and storage, which includes the design, manufacture, installation, sales, and leasing of solar energy generation and energy storage products, services related to such products, and sales of solar energy system incentives.

Translate Bio

Translate Bio is a clinical-stage messenger RNA (mRNA) therapeutics company. The company is engaged in developing medicines to treat diseases caused by protein or gene dysfunction. Using its proprietary mRNA therapeutic platform (MRT platform), the company creates mRNA that encodes functional proteins. The company is developing its MRT product candidate for the lung, MRT5005, for the treatment of cystic fibrosi, and MRT5201, for the treatment of ornithine transcarbamylase deficiency.

Twist Bioscience

Twist Bioscience is a synthetic biology company. The company is developing a disruptive DNA synthesis platform to industrialize the engineering of biology. The main of its platform is a proprietary technology that manufactures synthetic DNA by writing DNA on a silicon chip. The company has combined this technology with proprietary software, scalable commercial infrastructure and an e-commerce platform to create a technology platform. The company's offerings consists of two primary products that address different needs of its customers across a variety of applications: synthetic genes, oligonucleotide (oligo) pools, next generation sequencing tools and DNA libraries.

Unity Software

Virgin Galactic Holdings (A)

Zentalis Pharmaceuticals

Provider
Vermilion Research
Vermilion Research

Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.

Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.

Analysts
Dave Nicoski

Ross LaDuke

Other Reports on these Companies
Other Reports from Vermilion Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch